Source: Annual Congress 2007 - Novel therapies for severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. L. Johnston (London, United Kingdom). Targeting viruses and bacteria. Annual Congress 2007 - Novel therapies for severe asthma

Member's Comments

No comment yet.

Related content which might interest you: Epidemiology and biology of the common respiratory viruses, atypical bacteria, and bacteria Source: Annual Congress 2004 - PG9 - The role of infection in airway inflammation and exacerbation Year: 2004 The role of bacteria and viruses in lung disease Source: International Congress 2016 – Diseases and defences of the respiratory mucosa Year: 2016 The role of viruses and other atypical bacteria in bronchiectasis‘ exacerbations Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis Year: 2011 Broccoli sprout homogenates and live attenuated influenza virus: Effect on peripheral blood natural kill cells Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015 IP-10 is selectively produced in the airways upon respiratory virus infection Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection Year: 2013 Cationic host defence peptides as a novel treatment for respiratory viral infections Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung Year: 2018 An innate defence role for BPIFA1/SPLUNC1 against influenza-A virus infection Source: International Congress 2015 – The multiple faces of host defense Year: 2015 Glycosylation studies of G-protein of BA genotype of group B human respiratory syncytial virus in mammalian cells Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues Year: 2015 The role of viruses in CAP Source: Eur Respir Monogr 2014; 63: 74-87 Year: 2014 Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo Source: International Congress 2016 – Cystic fibrosis: various aspects Year: 2016 Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia Source: Virtual Congress 2020 – Translational science in respiratory infections Year: 2020 Biomarkers of bacterial infection Source: Annual Congress 2008 - Is microbiological diagnosis of community-acquired pneumonia possible and useful? Year: 2008 Bronchiectasies. Colonisation with potential pathogenic bacteria in stable clinical conditions Source: Eur Respir J 2005; 26: Suppl. 49, 641s Year: 2005 Viruses and bacteria in paediatric asthma Source: International Congress 2016 – PG8 Paediatric asthma Year: 2016 The ancient rubredoxin system: An efficient defense mechanism of pseudomonas aeruginosa during infections Source: International Congress 2014 – Immunology of respiratory infections Year: 2014 From environmental bacteria to obligate pathogen: the study of adaptations enhancing the persistence of tuberculosis bacilli Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020